Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine add-on trial in schizophrenia
ACTRN12605000577617Phase 4Completed
- Sponsor
- University of Melbourne
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mirtazapine in schizophrenia (2 arms), sponsored by University of Melbourne. Primary endpoint: Positive and Negative Syndrome Scale. Started Jun 2004; status: completed.
02
Drugs
mirtazapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ACTRN12605000577617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000577617.